Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 02:56PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-33.00 Insider Own5.10% Shs Outstand1.28M Perf Week6.39%
Market Cap3.94M Forward P/E- EPS next Y-2.26 Insider Trans0.00% Shs Float1.21M Perf Month-13.96%
Income-18.61M PEG- EPS next Q0.64 Inst Own4.52% Short Float / Ratio0.37% / 0.00 Perf Quarter-52.01%
Sales7.75M P/S0.51 EPS this Y94.51% Inst Trans- Short Interest0.00M Perf Half Y-63.97%
Book/sh-1.06 P/B- EPS next Y37.05% ROA-76.33% Target Price5.00 Perf Year-82.89%
Cash/sh6.81 P/C0.45 EPS next 5Y- ROE-973.16% 52W Range2.78 - 24.30 Perf YTD-81.07%
Dividend- P/FCF- EPS past 5Y80.37% ROI- 52W High-87.32% Beta1.36
Dividend %- Quick Ratio0.55 Sales past 5Y-2.34% Gross Margin29.84% 52W Low10.79% ATR0.32
Employees71 Current Ratio0.85 Sales Q/Q-19.32% Oper. Margin-204.49% RSI (14)41.27 Volatility10.56% 6.68%
OptionableNo Debt/Eq- EPS Q/Q74.60% Profit Margin-240.18% Rel Volume0.01 Prev Close3.16
ShortableYes LT Debt/Eq- EarningsOct 26 AMC Payout- Avg Volume1.94M Price3.08
Recom1.00 SMA20-3.70% SMA50-24.11% SMA200-64.35% Volume20,859 Change-2.53%
Date Action Analyst Rating Change Price Target Change
Jun-29-21Initiated B. Riley Securities Buy $2.50
Mar-09-18Initiated Ladenburg Thalmann Buy
Apr-12-17Downgrade Oppenheimer Outperform → Perform
Apr-11-17Downgrade Canaccord Genuity Buy → Hold $4.30 → $1
Dec-29-15Downgrade Dougherty & Company Buy → Neutral
May-08-15Reiterated Dougherty & Company Buy $16 → $18
Apr-29-15Initiated Dougherty & Company Buy $16
Feb-24-15Initiated Oppenheimer Outperform $15
Feb-24-15Initiated Canaccord Genuity Buy $18
Oct-27-23 08:24AM
Oct-26-23 06:40PM
Oct-19-23 08:00AM
08:00AM Loading…
Sep-27-23 08:00AM
Sep-18-23 08:00AM
Aug-25-23 12:38PM
Aug-24-23 08:00AM
Aug-04-23 09:00AM
Jul-28-23 06:15AM
Jul-27-23 06:35PM
Jul-20-23 08:00AM
08:00AM Loading…
Jun-20-23 08:00AM
Jun-09-23 08:00AM
Jun-07-23 08:00AM
Jun-05-23 08:00AM
May-11-23 05:28AM
May-10-23 04:36PM
May-02-23 08:00AM
Apr-28-23 08:00AM
Apr-26-23 08:00AM
Mar-16-23 07:35AM
Mar-15-23 04:20PM
Mar-02-23 08:00AM
Jan-11-23 08:15AM
08:02AM Loading…
Nov-12-22 08:02AM
Nov-09-22 04:01PM
Nov-04-22 08:00AM
Nov-01-22 07:45AM
Oct-19-22 08:00AM
Sep-07-22 08:30AM
Sep-01-22 08:00AM
Aug-11-22 04:30PM
Aug-08-22 03:15PM
Aug-05-22 08:00AM
Aug-04-22 08:00AM
Jul-06-22 08:00AM
Jun-21-22 07:30AM
Jun-15-22 08:30AM
Jun-06-22 08:30AM
May-16-22 08:00AM
May-10-22 05:55PM
May-04-22 07:45PM
Apr-29-22 09:00AM
Apr-19-22 08:00AM
Mar-30-22 08:00AM
Mar-29-22 04:05PM
Mar-22-22 05:15PM
Mar-15-22 07:30AM
Mar-14-22 08:00AM
Mar-08-22 08:55AM
Mar-07-22 07:30AM
Mar-02-22 07:58AM
Feb-28-22 08:15AM
Feb-24-22 05:30PM
Feb-22-22 05:55PM
Jan-14-22 04:01PM
Jan-12-22 08:00AM
Jan-11-22 08:30AM
Nov-17-21 12:45PM
Nov-11-21 04:01PM
Nov-04-21 03:01PM
Oct-29-21 08:30AM
Oct-07-21 11:00AM
Sep-08-21 08:45AM
Sep-03-21 07:38AM
Aug-16-21 08:00AM
Aug-10-21 04:01PM
Aug-09-21 07:30AM
Jul-27-21 04:00PM
Jul-22-21 09:20AM
Jul-06-21 08:30AM
Jun-28-21 08:45AM
Jun-13-21 02:37PM
Jun-07-21 08:00AM
May-25-21 08:30AM
May-17-21 08:00AM
May-09-21 03:35AM
May-06-21 04:01PM
Apr-26-21 08:30AM
Apr-21-21 08:00AM
Apr-15-21 08:00AM
Apr-08-21 08:30AM
Mar-11-21 04:50PM
Mar-10-21 10:08AM
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Subainati Nabeel PaulVice President, FinanceMar 23Sale0.8122318185,672Mar 24 04:36 PM